Highline Wealth Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Highline Wealth Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.01K	Hold	38	–	–	﹤0.01%	1036
2026 Q1	$2.85K	Hold	38	–	–	﹤0.01%	927
2025 Q4	$3.01K	Hold	38	–	–	﹤0.01%	732
2025 Q3	$2.49K	Hold	38	–	–	﹤0.01%	814
2025 Q2	$1.5K	Hold	38	–	–	﹤0.01%	673
2025 Q1	$1.15K	Buy	+38	New	+$1.24K	﹤0.01%	722

Other funds holding IONS

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Westmount Partners Los Angeles, California $457M AUM 31.05% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return